Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide

Colloids Surf B Biointerfaces. 2012 Jan 1:89:79-85. doi: 10.1016/j.colsurfb.2011.08.026. Epub 2011 Sep 8.

Abstract

The synthesis, characterization, and toxicity of graphene oxide and reduced graphene oxide are reported. Prior to the cytocompatibility tests the stability of the suspensions in a wide range of concentrations (3.125-100 μg/mL) of three different dispersants is studied. Polyethylene glycol (PEG), polyethylene glycol-polypropylene glycol-polyethylene glycol (Pluronic P123), and sodium deoxycholate (DOC) are investigated as the dispersants. The toxicity depends on the type of dispersant and concentration of the nanomaterials in the suspensions. Detailed analysis suggests that graphene oxide functionalized with PEG in the concentration range between 3125 μg/mL and 25 μg/mL exhibits the best biocompatibility with mice fibroblast cells (line L929).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials*
  • Graphite / chemistry*
  • Microscopy, Electron, Transmission
  • Oxidation-Reduction
  • Spectrophotometry, Infrared
  • Spectroscopy, Fourier Transform Infrared
  • Spectrum Analysis, Raman
  • Thermogravimetry
  • X-Ray Diffraction

Substances

  • Biocompatible Materials
  • Graphite